Madrigal Shares Rise 12% After Resmetirom Gets Breakthrough

By Chris Wack


Madrigal Pharmaceuticals Inc. shares were up 12% to $287.57 on Tuesday after the company said that its resmetirom has received Breakthrough Therapy designation from the U.S. Food... | April 18, 2023

Related Keywords

Pennsylvania , United States , Chris Wack , Drug Administration , Madrigal Pharmaceuticals Inc , Breakthrough Therapy , Dow Jones , Madrigal Pharmaceuticals , Nc Stock Exchange , News , Information , Press Release , Y , Chris , Back , Madrigal , Pharmaceuticals , Hares , Were , P , O , N , Tuesday , After , The , Company , Aid , Hat , Its , Resmetirom , Gas , Eceived , Breakthrough , Therapy , Resignation , Rom , He Mdgl Us5588681057 ,